Often overlooked as a mortality risk, Diabetic Neuropathy (DN) is a serious diabetes complication that may affect as many as 50% of people with diabetes. The Diabetic Neuropathy Device™ is a non-invasive and painless FDA Cleared medical device that instantly identifies, grades, and maps predictive biomarkers for small nerve fibers using variable temperatures and large nerve fibers using vibrations. Test completed in less than 1-minute. Reimbursement $120-$260 national average. No other medical device in the market today has multi-objective abilities to identify and grade specific sites on ALL peripheral extremities (hands, legs, feet, etc.) that may potentially determine and prevent the likelihood of ulcers from forming. It is imperative that the proper diagnosis requires proper neurological examinations that objectively measure the specific nerve fibers (small, large, and mixed) per extremity so that the appropriate therapies may be targeted toward the disorder. The proper diagnosis of diabetic neuropathy requires tools with the ability to measure the disorder quantitatively for the different types of abnormalities that occur to specific nerve fibers.

Insurance: PPO, HMO, Personal Injury, VA, Work Comp, Medicare, Medicaid, TriCare

States Excluded:

Compensation: $2,000

Pay Cycle: Within 48-72 hours of delivery

Categories: Ancillary Services, Equipment, Practice Enhancement Tools, Regenerative Medicine,

Specialties: Cardiology, Chiropractic, Dermatology, Endocrinology, Family Medicine, Functional Medicine, General Surgery, Geriatrics, Hair Loss, Internal Medicine, Long-Term Care, Med Spa, Neurology, Neurosurgery, Ob / Gynecology, Occupational Medicine, Orthopedic Surgeon, Pain Management, Physical Medicine, Podiatry, Urgent Care,

Ancillary Program Status